BENZODIAZEPINE - ANVISA Registration 80258020049
Access comprehensive regulatory information for BENZODIAZEPINE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80258020049 and manufactured by GUANGZHOU WONDFO BIOTECH CO., LTD.. The registration is held by CEPALAB LABORATÓRIOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including MICROGENICS CORPORATION, SIEMENS HEALTHCARE DIAGNOSTICS INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80258020049
25351553954201718
02248312000144
Company Information
Dates and Status
Feb 14, 2018
VIGENTE
09/18/2025 19:00:01
MICROGENICS CORPORATION• United States of America
SIEMENS HEALTHCARE DIAGNOSTICS INC.• United States of America
ROCHE DIAGNOSTICS GMBH• Germany
RECIPE CHEMICALS INSTRUMENTS GMBH• Germany
INNOVACON, INC.• United States of America
BENZODIAZEPINA
ClinMass® TDM Kit System Benzodiazepines in Serum / Plasma em família
RECIPE CHEMICALS INSTRUMENTS GMBH
81086830042
Jan 20, 2022
BENZODIAZEPINA
Família Alinity c Benzodiazepines
MICROGENICS CORPORATION
80146502314
Nov 26, 2020
BENZODIAZEPINA
Alinity c Serum Benzodiazepines Reagent Kit
MICROGENICS CORPORATION
80146502285
Sep 08, 2020
BENZODIAZEPINA
SureStep One Step Benzoadiazepines Test Strip (Urine)
INNOVACON, INC.
10071770904
Jul 27, 2020
BENZODIAZEPINA
BNZ2 (ONLINE DAT Benzodiazepines II)_cobas c
ROCHE DIAGNOSTICS GMBH
10287411483
Mar 09, 2020

